Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

First Update in Nearly 10 Years by FITTER Forward Initiative Sets Out to Transform Insulin Injection Technique EducationPARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") ...

AI-powered, internet-connected medical devices have the potential to revolutionize health care by enabling early disease ...

An alleged prototype of the Apple Watch Series 10 has a brand new sensor that may have been intended for blood sugar ...

Scientists at the Łódź University of Technology in central Poland have developed a new light-based therapy device designed to support home treatment of diabetic foot syndrome, a serious ...

The future of wearable foot technology is promising, however. Devices are becoming smaller, more affordable and easier to use ...

New smartwatch research has revealed the potentially transformative impact of smartwatches on diabetes patients Data ... and best fitness trackers. Devices like the best Apple Watches come with ...

Combination treatment with a GLP-1 agonist and thiazolidinedione in type 2 diabetes was tied to a significantly lower risk of ...

A new report for the Patent Safety Commissioner explored the challenges faced by people with sensory impairment.

Ex-Intel head says TSMC’s new investment will not resurrect US chip sector Read the Market Summary Here:- Global Blood Glucose Monitoring System Market is valued at approximately USD 16.46 billion in ...

It’s not just pharma companies driving this change – companies with digital diabetes devices are also positioning themselves to be key players. Dexcom is one of a new breed of companies ...